Letters to the Editor

Goldbloom OS Garfinkel PE . Psychiatric practice for the coming decade. Can J Psychiatry 1996;41: 156–60.

van Reekum R Links PS Mitton MJE Fedorov C Patrick J . Impulsivity, defensive functioning, and borderline personality disorder. Can J Psychiatry 1996;41: 81–4.

Kindlon D Mezzacappa E Earls F . Psychometric properties of impulsivity measures: Temporal stability, validity and factor structure. J Child Psychol Psychiatry 1995;36:645–61.

Hooberman D Stern TA . Treatment of attention deficit and borderline personality disorders with psychostimulants: Case report. J Clin Psychiatry 1984;45: 441–2.

Links PS Steiner M . Psychopharmacologic management of patients with borderline personality disorder. Can J Psychiatry 1988;33:355–9.

Remington GJ Addington D Collins EJ Jones BD Lalonde P MacCrimmon DJ , and others. Clozapine: Current status and role in the pharmacotherapy of schizophrenia. Can J Psychiatry 1996;41:161–6.

Remington GJ Addington D Collins EJ Jones BD Lalonde P MacCrimmon DJ , and others. Clozapine: Current status and role in the pharmacotherapy of schizophrenia. Can J Psychiatry 1996;41:161–6.

Zarate CA Tohen M Baldessarini RJ . Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411–7.

Suppes T McElroy SL Gilbert J Dessain EC Cole PJ . Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270–80.

McKay AP Tarbuck AF Shapleske J McKenna PJ . Neuropsychological function in manic-depressive psychosis: Evidence for persistent deficits in patients with chronic, severe illness. Br J Psychiatry 1995;167:51–7.

Andreasen NC Rezai K Alliger R Sawyze V Flaum M Kirchner P , and others. Hypofrontality in neuroleptic naive patient and patients with chronic schizophrenia: Assessment with xenon 133 photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992;49:943–58.

Lewander T . Neuroleptic and the neuroleptics induced deficit syndrome. Acta Psychiatr Scand 1994;89(380 Suppl):8S–13S.

Moghaddam B . Preferential activation of cortical dopamine neurotransmission by clozapine: Functional significance. J Clin Psychiatry 1994;55(B Suppl):9S.

Goldberg TE Bigelow LB Weinberger DR Daniel DG Kleinman J . Cognitive and behavioral effect of coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 1991;148:1.

Weinberger DR Berman KF Chase TN . Mesocortical dopaminergic function and human cognition. Ann N Y Acad Sci 1988;537:330–8.

Carpenter WT Conley RR Buchanan RW Breier A Tamminga CA . Patient response and resource management: Another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995;152:827–32.

Meltzer HY Yamamoto BK Lowy MT Stockmeier CA . The mechanism of action of atypical antipsychotic drugs: An update. In: Watson SJ Aril H , editors. Biology of schizophrenia and affective disease. ARNMD series. New York: Raven Press; 1995.

Steinberg JL Graver DL Moeller FG , and others. Serum homovanillic acid level in schizophrenic patients and normal control subjects. Psychiatry Res 1993;48:93–106.

Gardner EL Chen J Paredes W . Clozapine produces anti-dopaminergic effect anatomically specific to mesolimbic symptoms. J Clin Psychiatry 1994;55:(B Suppl): 15S–22S.

Meltzer HY Kennedy J Dai J Para M Riley D . Plasma clozapine level and the treatment of L-dopa induced psychosis in Parkinson's disease: A high potency effect of clozapine. Neuropsychopharmacology 1995; 12:39–45.

Kane J Honigfeld G Singer J , and others. Clozapine for the treatment resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–96.

Meltzer HY . Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992;515–42.

Lieberman JA Kane JM Johns CA . Clozapine: Guidelines for clinical management. J Clin Psychiatry 1989;50:329–38.

Safferman A Lieberman JA Kane JM , and others. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991;17:247–61.

Baldessarini R Frankeburg F . Clozapine: A novel antipsychotic agent. N Engl J Med 1991; 324:746–54.

Martin SD . Drug-induced parotid swelling [letter]. Br J Hosp Med 1993;50:426.

Dave M . Iatrogenic salivary gland swelling. J Pharm Technol 1995;11:18–20.

Vasile JS Steingard S . Clozapine and the development of salivary gland swelling: A case study. J Clin Psychiatry 1995;56:511–3.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association. 1994.

Harrison TR . Principles of internal medicine: International student edition. 9th ed. 1980.

Netter FH . Inflammations of salivary gland. In: Netter FH , editor. The Ciba collection of medical illustrations. Volume 3, Digestive system, part 1: Upper digestive tract. New York: Color Press; 1959. p 115.

Geocaris K . Psychotic episodes heralding the diagnosis of multiple sclerosis. Bull Menninger Clin 1957;21:107–16.

Matthews WB . Multiple sclerosis presenting with acute remitting psychiatric symptoms. J Neurol Neurosurg Psychiatry 1979;42:859–63.

Köhler J Heilmeyer H Volk B . Multiple sclerosis presenting as chronic atypical psychosis. J Neurol Neurosurg Psychiatry 1988;51:281–4.

Neumann PE Mehler MF Horoupian DS Merriam AE . Atypical psychosis with disseminated subpial demyelination. Arch Neurol 1988;45:634–6.

Huws R Shubsachs AP Taylor PJ . Hypersexuality, fetishism, and multiple sclerosis. Br J Psychiatry 1991;158:280–1.

Garland EJ Zis AP . Multiple sclerosis and affective disorder. Can J Psychiatry 1991;36:112–7.

Mahler ME . Behavior manifestations associated with multiple sclerosis. Psychiatr Clin North Am 1992;15:425–38.

Feinstein A du Boulay G Ron MA . Psychotic illness in multiple sclerosis: A clinical and magnetic resonance imaging study. Br J Psychiatry 1992;161:680–5.

Buckley P Hutchinson M . Psychosis and multiple sclerosis. Br J Psychiatry 1993;162:422–3.

Drake ME . Acute paranoid psychosis in multiple sclerosis. Psychosomatics 1984;25:60–5.

Garfield DA . Multiple sclerosis and affective disorder: Two case reports of mania with psychosis. Psychother Psychosom 1985;44:25–33.

Izquierdo G Campoy F Mir J Gonzalez M Martinez-Parra C . Memory and learning disturbances in multiple sclerosis: MRI lesions and neuropsychological correlation. Eur J Radiol 1991;13:220–4.

Stenager E Knudsen L Jensen K . Psychiatric and cognitive aspects of multiple sclerosis. Semin Neurol 1990;10:254–61.

Arias Bal MA Vazquez-Barquero JL Pena C Miro J Berciano JA . Psychiatric aspects of multiple sclerosis. Acta Psychiatr Scand 1991;83:292–6.

Berlin CS . Fluoxetine withdrawal symptoms [letter]. J Clin Psychiatry 1996;57:93–4.

Ellison JM . SSRI withdrawal buzz [letter]. J Clin Psychiatry 1994;55:544–5.